共 151 条
[1]
Fossati N(2019)The emerging role of PET-CT scan after radical prostatectomy: still a long way to go Lancet Oncol 20 1193-1195
[2]
Gandaglia G(2019)(18)F-fluciclovine PET-CT and (68)Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial Lancet Oncol 20 1286-1294
[3]
Briganti A(2019)New metabolic tracers for detectable PSA levels in the post-prostatectomy setting: Is the era of melting glaciers upcoming? Transl Androl Urol 8 S538-S541
[4]
Montorsi F(2019)((68)Ga)-PSMA-PET/CT for the detection of postoperative prostate cancer recurrence: Possible implications on treatment volumes for radiation therapy Cancer Radiother 23 194-200
[5]
Calais J(2016)Pattern of progression after stereotactic body radiotherapy for oligometastatic prostate cancer nodal recurrences Clin Oncol (R Coll Radiol) 28 e115-e120
[6]
Ceci F(2017)Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study Br J Cancer 116 1520-1525
[7]
Eiber M(2019)MR-guidance in clinical reality: current treatment challenges and future perspectives Radiat Oncol 14 92-725
[8]
Hope TA(2020)Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy Radiat Oncol 15 178-S150
[9]
Hofman MS(2018)Could 68-Ga PSMA PET/CT become a new tool in the decision-making strategy of prostate cancer patients with biochemical recurrence of PSA after radical prostatectomy? A preliminary, monocentric series Radiol Med 123 719-863
[10]
Rischpler C(2009)From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors J Nucl Med 50 122S-453